UBS Sees Upside for UnitedHealth (UNH) Amid Medicare Advantage Restructuring

Group 1 - UnitedHealth Group Incorporated (NYSE:UNH) is considered one of the best cheap rising stocks to invest in, with UBS maintaining a $378 price target and Buy rating as of September 19 [1] - The company has not made adjustments to its second-half cost trends projections across core business lines, with Medicaid and Commercial segments remaining consistent with earlier statements [1] - UnitedHealth disclosed plans to withdraw from Medicare Advantage plans affecting 600,000 people in PPO packages, with a total loss expected for the insurance segment [2] Group 2 - The decision to pull commissions on specific Medicare Advantage plans mainly impacts PPO plans, which the company has no plans to expand [3] - UnitedHealth operates through four main segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx [3]